BIOMARKER:

SAMHD1 expression

Entrez ID:

Related biomarkers:

‹

›

SAMHD1 expression SAMHD1 expression	Ovarian Cancer Ovarian Cancer	Platinum alkylating agent Resistant: C3 – Early Trials EACR 2021 - 3 weeks
SAMHD1 expression SAMHD1 expression	Non Small Cell Lung Cancer NSCLC	Platinum alkylating agent Resistant: C3 – Early Trials EACR 2021 - 3 weeks
SAMHD1 expression SAMHD1 expression	Breast Cancer Breast Cancer	capecitabine Resistant: C3 – Early Trials EACR 2021 - 3 weeks
SAMHD1 expression SAMHD1 expression	Ovarian Cancer Ovarian Cancer	gemcitabine Resistant: C3 – Early Trials EACR 2021 - 3 weeks
SAMHD1 expression SAMHD1 expression	Ovarian Cancer Ovarian Cancer	Platinum alkylating agent + gemcitabine Resistant: C3 – Early Trials EACR 2021 - 3 weeks

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

Associations